Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Novel synthesis method for N-N axis chiral compounds delivering high ee and mild conditions. Reliable supplier for pharma intermediates ensuring cost reduction.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Patent CN117720537B reveals a novel indole-furan catalyst enabling high-purity asymmetric synthesis with significant cost reduction in fine chemical manufacturing and supply chain reliability.
Patent CN102718659B enables high-yield synthesis of 4-bromo-2-nitrophenylacetic acid. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN116768904B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for antitumor intermediates. Enables scalable manufacturing processes.
Patent CN114315536A reveals a metal-free method for synthesizing axial chiral diarylethenes with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115286504B details asymmetric hydrogenation for brivaracetam intermediate. Delivers high purity and supply chain stability for global pharmaceutical manufacturing.
Patent CN112441978B reveals a novel route for MHPE production using DEMME, offering significant cost reduction and high purity for Topramezone manufacturing.
Novel chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability ensuring consistent quality for global drug development pipelines.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with mild conditions and scalable supply chain reliability for global partners.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN110452150A reveals efficient synthesis of axial chiral indole-naphthalene compounds. Offers cost reduction in specialty chemical manufacturing and reliable supply chain solutions.
Novel synthesis patent CN116199614B offers high enantioselectivity and cost-effective manufacturing for reliable pharmaceutical intermediates supplier partnerships ensuring supply chain continuity.
A novel two-step method for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yields and simplified purification for pharmaceutical supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Novel metal-free catalytic synthesis for high-purity pharmaceutical intermediates ensuring cost reduction and supply reliability for global drug development.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Achieve cost reduction in pharmaceutical manufacturing with scalable, high-purity routes.
Discover a novel asymmetric synthesis method for axially chiral indole-naphthalene compounds using chiral phosphoric acid. High enantioselectivity and mild conditions for API manufacturing.
Novel binaphthyl phosphoric acid catalyzed synthesis of isoindolinone imines. High yield, mild conditions, suitable for commercial scale-up in pharmaceutical manufacturing.